Texas Capital Bancshares Inc/Tx (TCBIO) EBIT Margin (2010 - 2026)

Texas Capital Bancshares (TCBIO) has reported EBIT Margin for 17 consecutive years, with 86.9% the latest figure, recorded in Q2 2026.

• Quarterly EBIT Margin fell 688.0% year-over-year to 86.9% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 91.69% (down 1210.0% YoY) and the FY2025 annual result came in at 96.29%, down 363.0% from the prior year.
• EBIT Margin declined to 86.9% in Q2 2026 per TCBIO's latest filing, from 89.31% in the prior quarter.
• Over the last five years, EBIT Margin for TCBIO reached as high as 943.76% in Q2 2023 and fell as low as 10044.2% in Q3 2023.
• A 5-year average of 362.26% and a median of 93.23% in 2023 frame the typical range for EBIT Margin.
• Annual changes were most pronounced in 2023 — EBIT Margin plunged 1009653 bps — and 2024, when it soared 1014987 bps.
• Year by year, EBIT Margin stood at 76.51% in 2022, then increased by 21 bps to 92.67% in 2023, then jumped by 43 bps to 132.74% in 2024, then dropped by 29 bps to 94.41% in 2025, then slipped by 8 bps to 86.9% in 2026.
• According to Business Quant data, EBIT Margin over the past three periods registered 86.9%, 89.31%, and 94.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.